PRTC Stock Analysis: Buy, Sell, or Hold?
PRTC - PureTech Health plc American Depositary Shares
$17.42
0.34 (1.99%)
â˛
5d:
-0.51%
30d:
-3.49%
90d:
-2.16%
WAIT
LOW Confidence
Analysis Updated: May 20, 2026 12:00 AM ET
Earnings: Aug 27, 2026
17d
Get Alerted When PRTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: PRTC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: PRTC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: PRTC is currently trading at $17.42, which is considered fair based on recent price action.
Technical Outlook: Technically, PRTC is showing sideways momentum. Immediate support is located at $16.73, while resistance sits at $18.61.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $46.00 (+164.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRTC is showing sideways momentum. Immediate support is located at $16.73, while resistance sits at $18.61.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $46.00 (+164.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
51/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: Trading 164.1% below Wall St target ($46.00)
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Support & Resistance Levels
Support Level
$16.73
Resistance Level
$18.61
Current Trend
Sideways
Technical data as of
May 20, 2026
Fundamental Context
Wall Street Target
$46.00
(+164.1%)
Revenue Growth (YoY)
-38.2%
Earnings Growth (YoY)
61.5%
Share & Embed Analysis
Last updated: August 09, 2026 4:14 AM ET
Data refreshes hourly during market hours. Next update: 5:14 AM
Data refreshes hourly during market hours. Next update: 5:14 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
29 analysts |
$88 | 47 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 63 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 47 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$105 | 49 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 43 HOLD |
